Updated on 16 July 2012
Dr Mike Harrington, vice president - European and Asia Pacific Operations, Waters, France
Waters India, a fully owned subsidiary of Waters in the US, is celebrating its silver jubilee anniversary in India. Driven by a long-term commitment to the region, Waters invested in India through a joint venture with local partners in 1988. Since then, it has consistently invested in its India operations to create the best infrastructure and world-class application and demonstration laboratories. A team of more than 250 highly dedicated and qualified scientists and engineers support its growing customer base.
Waters India is current expanding its headquarters in Bangalore with improved laboratories, upgraded training facilities and more office space. When completed, the new facility will be approximately 16,000 square feet in area. BioSpectrum speaks to Dr Mike Harrington, vice president - European and Asia Pacific Operations, Waters, France, about his views on the market opportunities for the company in Asia Pacific and the company's strategies for growth in the region on the sidelines of his visit to India recently. Excerpts of the interview:
What are your investment plans for India?
Our investment in India is an ongoing process. We have invested in a new application laboratory in Bangalore, which caters to developing solutions for Indian customers and increase the knowledge base of trained individuals. There would be additional investments in the coming months as well. We are making large investment to set up a center for clinical application called Center for Regulated Bio-Application Development to support our clients around the world.
How do you see the market trends in the Asia Pacific region?